rs73424032
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001112741.2(KCNC1):c.677A>T(p.Asn226Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000052 in 1,614,242 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. N226N) has been classified as Likely benign.
Frequency
Consequence
NM_001112741.2 missense
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics
- progressive myoclonic epilepsy type 7Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P
- progressive myoclonus epilepsyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KCNC1 | NM_001112741.2 | c.677A>T | p.Asn226Ile | missense_variant | Exon 2 of 4 | ENST00000265969.8 | NP_001106212.1 | |
| KCNC1 | NM_004976.4 | c.677A>T | p.Asn226Ile | missense_variant | Exon 2 of 2 | NP_004967.1 | ||
| KCNC1 | XM_047426916.1 | c.677A>T | p.Asn226Ile | missense_variant | Exon 2 of 4 | XP_047282872.1 | ||
| KCNC1 | XR_930866.3 | n.1899A>T | non_coding_transcript_exon_variant | Exon 2 of 3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152240Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000517 AC: 13AN: 251484 AF XY: 0.0000441 show subpopulations
GnomAD4 exome AF: 0.0000322 AC: 47AN: 1461884Hom.: 0 Cov.: 31 AF XY: 0.0000248 AC XY: 18AN XY: 727242 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000243 AC: 37AN: 152358Hom.: 0 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74514 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Progressive myoclonic epilepsy type 7 Benign:1
- -
not provided Benign:1
The KCNC1 p.Asn226Ile variant was not identified in the literature nor was it identified in Cosmic or LOVD 3.0. The variant was identified in dbSNP (ID: rs73424032) and ClinVar (classified as a VUS by Invitae and as likely benign by Ambry Genetics). The variant was also identified in control databases in 19 of 282884 chromosomes at a frequency of 0.000067 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 17 of 24966 chromosomes (freq: 0.000681), Other in 1 of 7226 chromosomes (freq: 0.000138) and Latino in 1 of 35436 chromosomes (freq: 0.000028), while the variant was not observed in the Ashkenazi Jewish, East Asian, European (Finnish), European (non-Finnish) or South Asian populations. The p.Asn226 residue is not conserved in mammals and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at